Poseida Therapeutics, Inc. Annual Interest Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Poseida Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2019 to 2023.
  • Poseida Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2024 was $2.3M, a 2.64% increase year-over-year.
  • Poseida Therapeutics, Inc. Interest Expense for the twelve months ending September 30, 2024 was $9.07M, a 20.9% decline year-over-year.
  • Poseida Therapeutics, Inc. annual Interest Expense for 2023 was $8.67M, a 36.1% increase from 2022.
  • Poseida Therapeutics, Inc. annual Interest Expense for 2022 was $6.37M, a 89.7% increase from 2021.
  • Poseida Therapeutics, Inc. annual Interest Expense for 2021 was $3.36M, a 4.22% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $8.67M +$2.3M +36.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $6.37M +$3.01M +89.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $3.36M -$148K -4.22% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $3.51M -$47K -1.32% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $3.55M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.